Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure

This publication has 63 references indexed in Scilit:

• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal Tissue
  Biochemical and Biophysical Research Communications, 2000
• Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the Rat
  Endocrinology, 1999
• Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
  The Lancet, 1998
• Wasting as independent risk factor for mortality in chronic heart failure
  Published by Elsevier ,1997
• Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.
  Journal of Clinical Investigation, 1996
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats
  Life Sciences, 1994
• Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
  Journal of Clinical Endocrinology & Metabolism, 1993